Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates


Development of resistance in Pseudomonas aeruginosa infection: case report

    • 4 Accesses

    This is a preview of subscription content, log in to check access.


    1. Boulant T, et al. A 2.5-Year Within-Patient Evolution of Pseudomonas aeruginosa Isolates with in Vivo Acquisition of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Resistance upon Treatment. Antimicrobial Agents and Chemotherapy 63: e01637-19, No. 12, Dec 2019. Available from: URL:

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Ceftolozane/tazobactam. Reactions Weekly 1790, 71 (2020).

    Download citation